The Gulf War depleted uranium cohort at 20 years: Bioassay results and novel approaches to fragment surveillance

Health Physics

Volumn 104, Issue 4, 2013, Pages 347-361

  McDiarmid, Melissa A ^a,b   Gaitens, Joanna M ^a,b   Hines, Stella ^a,b   Breyer, Richard ^b   Wong You Cheong, Jade J ^b   Engelhardt, Susan M ^a   Oliver, Marc ^a,b   Gucer, Patricia ^a,b   Kane, Robert ^a   Cernich, Alison ^a   Kaup, Bruce ^a,b   Hoover, Dennis ^a,b   Gaspari, Anthony A ^a,b   Liu, Juan ^b   Harberts, Erin ^b   Brown, Lawrence ^a,b   Centeno, Jose A ^c   Gray, Patrick J ^c   Xu, Hanna ^c   Squibb, Katherine S ^a,b  

^a BALTIMORE VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c Joint Pathology Center   (United States)

Author keywords

diagnostic imaging; excretion, urinary; exposure, radiation; uranium, depleted

Indexed keywords

BIOLOGICAL MARKER; METAL; URANIUM;

ARTICLE; COHORT ANALYSIS; DIAGNOSTIC IMAGING; HUMAN; IMMUNE SYSTEM; KIDNEY FUNCTION TEST; LUNG FUNCTION TEST; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; URINE; VETERAN; WAR;

BIOLOGICAL MARKERS; COHORT STUDIES; DIAGNOSTIC IMAGING; GULF WAR; HUMANS; IMMUNE SYSTEM; KIDNEY FUNCTION TESTS; MALE; METALS; MIDDLE AGED; OCCUPATIONAL EXPOSURE; RESPIRATORY FUNCTION TESTS; URANIUM; VETERANS;

EID: 84874611138     PISSN: 00179078     EISSN: 15385159     Source Type: Journal    
DOI: 10.1097/HP.0b013e31827b1740     Document Type: Article

References (74)

1. Agency for Toxic Substances and Disease Registry. Draft tox-icological profile for uranium. Washington, DC: U.S. Department of Health and Human Services, Public Health Service, ATSDR; 2011.
2. American Conference of Governmental Industrial Hygienists. Documentation of the threshold limit values and biological exposure indices. Cincinnati, OH: ACGIH; 1991.
3. Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Sem Immun 20:86-100; 2008.
4. Army Environmental Policy Institute. Health and environmental consequences of depleted uranium use in the U.S. army. Arlington, VA: AEPI; 1995.
5. Bagshaw SM, Langenberg C, Haase M, Wan L, May CN, Bellomo R. Urinary biomarkers in septic acute kidney injury. Intensive Care Med 33:1285-1296; 2007.
6. Bolignano D, Lacquaniti A, Coppolino G, Donato V, Campo S, Fazio MR, Nicocia G, Buemi M. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol 4:337-344; 2009.
7. Brand KG, Buoen LC, Johnson KH, Brand I. Etiological factors, stages and the role of the foreign body in foreign body tumorigenesis: a review. Cancer Res 35:279-286; 1975.
8. Burtis CA, Ashwood ER. Tietz fundamentals of clinical chemistry. Philadelphia: W.B. Saunders Company; 2001.
9. Chaturvedi S, Farmer T, Kapke GF. Assay validation for KIM1: human urinary renal dysfunction biomarker. Int J Biol Sci 5: 128-134; 2009.
10. Cleveland Clinic Laboratories. Test directory. Available at http://clevelandcliniclabs.com/TestDirectory/tabid/4191/Default.aspx. Accessed 13 February 2013.
11. Coca SG, Yalavarthy R, Concato J, Parikh CR. Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int 73:1008-1016; 2008.
12. Dillman RO, Crumb CK, Lidsky MJ. Lead poisoning from a gunshot wound: report of a case and review of the literature. Am J Med 66:509-514; 1979.
13. Ejnik JW, Todorov T, Mullick FG, Squibb KS, McDiarmid MA, Centeno JA. Uranium analysis in urine by inductively coupled plasma dynamic reaction cell mass spectrometry. Anal Bioanal Chem 382:73-79; 2005.
14. Fernald Environmental Management Project. Technical basis for internal dosimetry at the Fernald Environmental Management Project. Fernald, OH: FEMP; Pub. SD 2008; 1997.
15. Fries KM, Sempowski GD, Gaspari AA, Blieden T, Looney RJ, Phipps RP. CD40 expression by human fibroblasts. Clin Immunol Immunopathol 77:42-51; 1995.
16. Gaitens J, Dorsey CD, McDiarmid MA. Using a public health registry to conduct medical surveillance: the case of toxic embedded fragments in U.S. military veterans. European J Oncol 15:77-89; 2010.
17. Gaspari AA, Ferbel B, Chen A, Razvi F, Polakowska R. Accessory and alloantigen-presenting cell functions of A431 kera-tinocytes that stably express the B7 antigen. Cell Immunol 149:291-302; 1993.
18. Gaspari AA, Sempowski GD, Chess P, Gish J, Phipps RP. Human epidermal keratinocytes are induced to secrete interleukin-6 and co-stimulate T lymphocyte proliferation by a CD40-dependent mechanism. Eur J Immunol 26:1371-1377; 1996.
19. 238U isotope rations in human urine by inductively coupled plasma mass spec-trometry. Microchem J 105:94-100; 2012.
20. Hahn FF, Guillmette RA, Hoover MD. Implanted depleted uranium fragments cause soft tissue sarcomas in the muscles of rats. Environ Health Perspect 110:51-59; 2002.
21. Hallab NJ. Lymphocyte transformation testing for quantifying metal-implant-related hypersensitivity responses. Dermatitis 15:82-90; 2004.
22. Hallab NJ, Jacobs JJ. Biologic effects of implant debris. Bull NYU Hosp Jt Dis 67:182-188; 2009.
23. Hodge HC, Stannard JN, Hursh JB. Handbook of experimental pharmacology: uranium, plutonium, transplutonic elements. New York: Springer-Verlag; 1973.
24. Hooper FJ, Squibb KS, Siegel EL, McPhaul K, Keogh JP. Elevated urine uranium excretion by soldiers with retained uranium shrapnel. Health Phys 77:512-519; 1999.
25. Institute of Medicine. Long-term health consequences of exposure to burn pits in Iraq and Afghanistan. Washington, DC: The National Academies Press; 2011.
26. International Agency for Research on Cancer. Surgical implants and other foreign bodies, IARC monographs on the evaluation of carcinogenic risks to humans. Lyons, France: World Health Organization; Vol. 74; 1999.
27. International Commission on Radiologic Protection. Report of the task groups on reference man. Elmsford, NY: Pergamon Press; Vol. 23; 1974.
28. Jacobs JJ, Skipor AK, Patterson LM, Hallab NJ, Paprosky WG, Black J, Galante JO. Metal release in patients who have had a primary total hip arthroplasty. A prospective, controlled, longitudinal study. J Bone Joint Surg 80:1447-1458; 1998.
29. Karpas Z, Kirber A, Eliah E, Marcus P, Roiz Y, Marko R, Kol R, Brikner D, Halicz L. Uranium in urine-normalization to creatinine. Health Phys 74:86-90; 1998.
30. Keegan GM, Learmonth ID, Case CP. Orthopaedic metals and their potential toxicity in the arthroplasty patient: a review of current knowledge and future strategies. J Bone Joint Surg (Br) 89-B:567-573; 2007.
31. King MS, Eisenberg R, Newman JH, Tolle JJ, Harrell FE, Nian J, Ninan M, Lambright ES, Sheller JR, Johnson JE, Miller RF. Constrictive bronchiolitis in soldiers returning from Iraq and Afghanistan. N Engl J Med 365:222-230; 2011.
32. Kurttio P, Auvinen A, Salonen L, Saha H, Pekkanen J, Mäkeläinen I, Väisänen SB, Penttilä IM, Komulainen H. Renal effects of uranium in drinking water. Environ Health Persp 110:337-342; 2002.
33. Kurttio P, Harmoinen A, Saha H, Salonen L, Karpas Z, Komulainen H, Auvinen A. Kidney toxicity of ingested uranium from drinking water.AmJKidney Dis 47:972-982; 2006.
34. Landrigan PJ, Lioy PJ, Thurston G, Berkowitz G, Chen LC, Chillrud SN, Gavett SH, Georgopoulos PG, Geyh AS, Levin S, Perera F, Rappaport SM, Small C. Health and environmental consequences of the world trade center disaster. Environ Health Perspect 112:731-739; 2004.
35. Lauwerys RR, Hoet P. Industrial chemical exposure guidelines for biological monitoring. Boca Raton, FL: Lewis Publishers; 2001.
36. Leggett RW. The behavior and chemical toxicity of U in the kidney: a reassessment. Health Phys 57:365-383; 1989.
37. Machle W. Lead absorption from bullets lodged in tissues: report of two cases. JAMA 115:1536-1541; 1940.
38. McDiarmid MA, Keogh JP, Hooper FJ, McPhaul K, Squibb KS, Kane R, DiPino R, Kabat M, Kaup B, Anderson L, Hoover D, Brown L, Hamilton M, Jacobson-Kram D, Burrows B, Walsh M. Health effects of depleted uranium on exposed Gulf War veterans. Environ Res 82:168-180; 2000.
39. McDiarmid MA, Squibb K, Engelhardt S, Oliver M, Gucer P, Wilson PD, Kane R, Kabat M, Kaup B, Anderson L, Hoover D, Brown L, Jacobson-Kram D. Surveillance of depleted uranium exposed Gulf War veterans: health effects observed in an enlarged "friendly fire" cohort. J Occup Environ Med 43:991-1000; 2001.
40. McDiarmid MA, Engelhardt SM, Oliver M, Gucer P, Wilson PD, Kane R, Kabat M, Kaup B, Anderson L, Hoover D, Brown L, Handwerger B, Albertini RJ, Jacobson-Kram D, Thorne CD, Squibb KS. Health effects of depleted uranium on exposed Gulf War veterans: a 10-year follow-up. J Toxicol Environ Health, Part A 67:277-296; 2004.
41. McDiarmid MA, Engelhardt SM, Oliver M, Gucer P, Wilson PD, Kane R, Kabat M, Kaup B, Anderson L, Hoover D, Brown L, Albertini R, Gudi R, Jacobson-Kram D, Thorne CD, Squibb KS. Biological monitoring and surveillance results of Gulf War I veterans exposed to depleted uranium. Int Arch Occup Environ Health 79:11-21; 2006.
42. McDiarmid MA, Engelhardt SM, Oliver M, Gucer P, Wilson PD, Kane R, Cernich A, Kaup B, Anderson L, Hoover D, Brown L, Albertini R, Gudi R, Jacobson-Kram D, Squibb KS. Health surveillance of Gulf War I veterans exposed to depleted uranium: updating the cohort. Health Phys 93:60-73; 2007.
43. McDiarmid MA, Engelhardt SM, Dorsey CD, Oliver M, Gucer P, Wilson PD, Cernich A, Kaup B, Anderson L, Hoover D, Brown L, Albertini R, Gudi R, Squibb KS. Surveillance results of depleted uranium-exposed Gulf War I veterans: sixteen years of follow-up. J Toxicol Environ Health Part A 72:14-29; 2009.
44. McDiarmid MA, Engelhardt SM, Corsey CD, Oliver M, Gucer P, Gaitens JM, Kane R, Cernich A, Kaup B, Hoover D, Gaspari AA, Schvartsbeyn M, Brown L, Squibb KS. Longitudinal health ssurveillance in a cohort of Gulf War veterans 18 years after first exposure to depleted uranium. J Toxicol Environ Health Part A 74:678-691; 2011.
45. McDiarmid MA, Gaitens JM, Squibb KS. Uranium and thorium. In: Bingham E, Cohrssen B, eds. Patty's Toxicology. Vol 1; New York, NY: John Wiley and Sons; 2012; 769-816.
46. McLendon Clinical Laboratories, UNC Hospitals, Chapel Hill, NC 2012. Available at http://labs.unchealthcare.org/labstestinfo/p-tests/protein-u-24.htm or http://labs.unchealthcare.org/labstestinfo/m-tests/microalb-rand.htm. Accessed 25 January 2013.
47. Morris JF, Koski A, Johnson LC. Spirometric standards for health nonsmoking adults. Am Rev Respir Dis 103:57-67; 1971.
48. National Health and Nutrition Examination Survey. Second national report on human exposure to environmental chemicals. Atlanta, GA: Centers for Disease Control and Prevention; NCEH Publication No. 02-0716; 2003.
49. National Research Council. Review of toxicologic and radio-logic risks to military personnel from exposure to depleted uranium during and after combat. Washington DC: National Academy Press; 2008.
50. Office of the Special Assistant for Gulf War Illnesses. Environmental exposure report: depleted uranium in the Gulf (II). 2000. Washington, DC: U.S. Department of Defense; 2000. Available at www.gulflink.osd.mil/du-ii/. Accessed 10 August 2012.
51. Parikh CR, Abraham E, Ancukiewicz M, Edelstein CL. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol 16:3046-3052; 2005.
52. Parkhurst MA, Daxon EG, Lodde GM, Szrom F, Guilmette RA, Roszell LE, Falo GA, McKee CB. Depleted uranium aerosol doses and risks: summary of U.S. assessments. Columbus, OH: Battelle Press; 2005.
53. Prezant DJ, Weiden M, Banauch GI, McGuinness G, Rom WN, Aldrich TK, Kelly KJ. Cough and bronchial responsiveness in firefighters at the World Trade Center site. N Engl J Med 347:806-815; 2002.
54. Prozialeck, WC, Edwards JR, Lamar PC, Liu J, Vaidya VS., Bonventre JV. Experssion of kidney injury molecule-1 (KIM-1) in relation to necrosis and apoptosis during the early stages of Cd-induced proximal tubule injury. Toxicol Appl Pharmacol 238:306-314; 2009.
55. Saccomanno G. The contribution of uranium miners to lung cancer histogenesis. Recent Results Cancer Res 82:43-52; 1982.
56. Shvartsbeyn M, Tuchinda P, Gaitens J, Squibb KS, McDiarmid MA, Gaspari AA. Patch testing with uranyl acetate in veterans exposed to depleted uranium during the 1991 Gulf War and Iraqi conflict. Dermatitis 22:33-39; 2011.
57. Smith B, Wong CA, Smith TC, Boyko EJ, Gackstetter GD, Ryan MAK. Newly reported respiratory symptoms and conditions among military personnel deployed to Iraq and Afghanistan: a prospective population-based study. Am J Epidemiol 170: 1433-1442; 2009.
58. Squibb KS, McDiarmid MA. Depleted uranium exposure and health effects in Gulf War veterans. Philos Trans R Soc Lond B Biol Sci 361:639-648; 2006.
59. Squibb KS, Leggett RW, McDiarmid MA. Prediction of renal concentrations of depleted uranium and radiation dose in Gulf War veterans with embedded shrapnel. Health Phys 89: 267-273; 2005.
60. Squibb KS, Gaitens JM, Engelhardt SM, Centeno JA, Xu H, Gray P, McDiarmid MA. Surveillance for long-term health effects associated with depleted uranium exposure and retained embedded fragments in U.S. veterans. JOEM 54: 724-732; 2012.
61. Sunderman FW, Hopfer SM, Swift T, Rezuke WN, Ziebka L, Highman P, Edwards B, Folcik M, Gossling HR. Cobalt, chromium, and nickel concentrations in body fluids of patients with porous-coated knee or hip prostheses. J Orthop Res 7:307-315; 1989.
62. Swiontkowski MF, Agel J, Shwappach J, McNair P, Welch M. Cutaneous metal sensitivity in patients with orthopaedic injuries. J Orthop Trauma 15:86-89; 2001.
63. Szema AM, Salihi W, Savary K, Chen JJ. Respiratory symptoms necessitating spirometry among soldiers with Iraq/Afghanistan War Lung Injury. JOEM 53:961-965; 2011.
64. Tannenbaum A, ed. Toxicology of uranium. New York, NY: McGraw-Hill Book Col, Inc; 1951.
65. The Royal Society. The health hazards of depleted uranium munitions part I. Policy document 6/01. London, UK: Royal Society; 2001.
66. The Royal Society. The health effects of depleted uranium munitions. Summary. Policy document 6/02. London, UK: Royal Society; 2002.
67. Thun MJ, Baker DB, Steenland K, Smith AB, Halperin W, Berl T. Renal toxicity in uranium mill workers. Scand J Work Environ Health 11:83-90; 1985.
68. University of Iowa, Department of Pathology. Laboratory services handbook. 2012. Available at www.healthcare.uiowa. edu/path-handbook. Accessed 2 July 2012.
69. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention Centers for Disease Control. Fourth national report on human exposure to environmental chemicalsVupdated tables. 2012. Available at www.cdc.gov/exposurereport/pdf/FourthReport-UpdatedTables- Feb2012.pdf. Accessed 13 August 2012.
70. Voegtlin C, Hodge HC. Pharmacology and toxicology of uranium compounds. Vols1and2.New York: McGraw Hill; 1949.
71. Voegtlin C, Hodge HC, eds. Pharmacology and toxicology of uranium compounds. Vols 3 and 4. New York: McGaw-Hill; 1953.
72. Zamora ML, Tracy BL, Zielinski JM, Meyerhof DP, Moss MA. Chronic ingestion of uranium in drinking water: a study of kidney bioeffects in humans. Toxicol Sci 43:68-77; 1998.
73. Zamora ML, Zielinski JM, Moodie GB, Falcomer RA, Hunt WC, Capello K. Uranium in drinking water: Renal effects of lonf-term ingestion by an aboriginal community. Arch Environ Occup Health 64:228-241; 2009.
74. Zhou Y, Vaidya VS, Brown RP, Zhang J, Rosenzweig BA, Thompson KL, Miller TJ, Bonventre JV, Goering PL. Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury and chromium. Toxicol Sci 101: 159-170; 2008.